Skip to main content
. Author manuscript; available in PMC: 2019 Oct 24.
Published in final edited form as: JCO Precis Oncol. 2017 Jun 28;1:10.1200/PO.16.00067. doi: 10.1200/PO.16.00067

Fig 1.

Fig 1.

Overview of the biopsy and clinical testing workflow. (A) Schema of biopsy and testing. (B) Biopsy sites of the samples used for Clinical Laboratory Improvement Amendments (CLIA)–approved sequencing and PTEN immunohistochemistry testing. (C) List of 37 genes tested for mutation in the CLIA-certified GeneTrails Solid Tumor Genotyping Panel. CRPC, castration-resistant prostate cancer; OHSU, Oregon Health & Science University.